← Scroll for more →
Pelthos Therapeutics Inc. (PTHS)
Biological Products, (No Diagnostic Substances)
Latest Price
$10.15
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
5.82
P/B Ratio
1.74
Institutional Ownership
34.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 329.1K | $9.0M | 8.85% | -- | 2026-06-30 |
| Murchinson Ltd. | 304.3K | $8.0M | 8.18% | +8.0K | 2026-06-30 |
| Ikarian Capital, LLC | 256.6K | $7.0M | 6.90% | -- | 2026-06-30 |
| Boothbay Fund Management, LLC | 102.0K | $2.0M | 2.74% | +20.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 97.1K | $2.0M | 2.61% | +4.0K | 2026-06-30 |
| J. Goldman & Co LP | 38.1K | $1.0M | 1.02% | -12.3K | 2026-06-30 |
| Diadema Partners LP | 24.8K | -- | 0.67% | -- | 2026-06-30 |
| Wexford Capital LP | 22.4K | -- | 0.60% | -- | 2026-06-30 |
| Knott David M Jr | 22.1K | -- | 0.59% | +1.0K | 2026-06-30 |
| Citadel Advisors LLC | 15.0K | -- | 0.40% | -- | 2026-06-30 |